БРЕЦЕР
Active Ingredient: Bortezomib
Product Overview
About БРЕЦЕР
БРЕЦЕР is a prescription medication containing the active ingredient Bortezomib, used in the treatment of multiple myeloma and mantle cell lymphoma. It is a proteasome inhibitor that works by blocking the action of proteasomes, which are responsible for breaking down proteins in cells.
Key Benefits & Uses
- Treatment of multiple myeloma, including relapsed and refractory disease
- Treatment of mantle cell lymphoma
- Indicated for patients who have received at least two prior therapies
Active Ingredient & Action
Bortezomib, the active ingredient in БРЕЦЕР, works by binding to the 26S proteasome, a complex of proteins responsible for degrading ubiquitinated proteins. By inhibiting the proteasome, Bortezomib disrupts the normal functioning of cells, leading to cell cycle arrest and apoptosis in cancer cells.
Important Notes
БРЕЦЕР should only be used under the guidance of a healthcare professional. Common side effects include fatigue, nausea, diarrhea, and peripheral neuropathy. Patients should be monitored for signs of cardiac toxicity, including hypertension and cardiac arrhythmias. It is essential to follow the recommended dosing schedule and to report any adverse reactions to a healthcare professional promptly.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.
